Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 by David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> Two years since world-largest outbreak of acute watery diarrhoea and cholera, Yemen witnessing another sharp increase in reported cases with number of deaths continuing to increase 27/03/2019 by Editorial team [WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 by Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 by Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 by Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Experts Call For Global Accountability Mechanism For Access To Essential Medicines 10/12/2018 by David Branigan Global health experts, including senior officials at the World Health Organization, are calling for a global accountability mechanism for access to essential medicines, noting that a the lack of data on medicines affordability and national pharmaceutical expenditures has hindered this process, according a recent article published in UK medical journal The Lancet. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 by David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> On World AIDS Day: Big Breakthroughs On HIV Self-Testing 30/11/2018 by Health Policy Watch A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading -> Index Finds Five Companies Develop Majority Of Medicines For Poor 20/11/2018 by David Branigan A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading -> Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Two years since world-largest outbreak of acute watery diarrhoea and cholera, Yemen witnessing another sharp increase in reported cases with number of deaths continuing to increase 27/03/2019 by Editorial team [WHO News Release] From Geert Cappelaere, UNICEF Regional Director in the Middle East and North Africa and Dr Ahmed Al Mandhari, WHO Regional Director for the Eastern Mediterranean MUSCAT/ AMMAN/CAIRO, 26 March 2019 – “In Yemen, since the beginning of the year until 17 March, nearly 109 000 cases of severe acute watery diarrhoea and suspected […] Continue reading -> WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 by Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 by Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 by Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Experts Call For Global Accountability Mechanism For Access To Essential Medicines 10/12/2018 by David Branigan Global health experts, including senior officials at the World Health Organization, are calling for a global accountability mechanism for access to essential medicines, noting that a the lack of data on medicines affordability and national pharmaceutical expenditures has hindered this process, according a recent article published in UK medical journal The Lancet. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 by David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> On World AIDS Day: Big Breakthroughs On HIV Self-Testing 30/11/2018 by Health Policy Watch A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading -> Index Finds Five Companies Develop Majority Of Medicines For Poor 20/11/2018 by David Branigan A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading -> Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Board Resorts To Vote To Settle Israel Request To Remove Palestine Agenda Item 01/02/2019 by Catherine Saez In a rare occasion, the World Health Organization Executive Board today resorted to recorded voting to decide on a politically-charged question, as Israel requested the deletion of an agenda item for the next World Health Assembly relating to the health of Palestinians in occupied territories. The Board ultimately voted against removing the agenda item for the next WHA in May. Continue reading -> Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 by Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 by Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Experts Call For Global Accountability Mechanism For Access To Essential Medicines 10/12/2018 by David Branigan Global health experts, including senior officials at the World Health Organization, are calling for a global accountability mechanism for access to essential medicines, noting that a the lack of data on medicines affordability and national pharmaceutical expenditures has hindered this process, according a recent article published in UK medical journal The Lancet. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 by David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> On World AIDS Day: Big Breakthroughs On HIV Self-Testing 30/11/2018 by Health Policy Watch A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading -> Index Finds Five Companies Develop Majority Of Medicines For Poor 20/11/2018 by David Branigan A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading -> Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Tafenoquine – Milestone In Journey Towards Malaria Elimination 23/01/2019 by Elaine Ruth Fletcher Tafenoquine, the first new drug to be developed in over 60 years to treat relapsing malaria, has in fact been around since the late 1970s, when researchers with the US Walter Reed Army Institute of Research first took note of its antimalarial properties. But the drug’s potential to cure relapsing malaria caused by the Plasmodium vivax parasite, the less deadly but most widespread malaria species, has only been recently been recognised. Continue reading -> Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 by Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Experts Call For Global Accountability Mechanism For Access To Essential Medicines 10/12/2018 by David Branigan Global health experts, including senior officials at the World Health Organization, are calling for a global accountability mechanism for access to essential medicines, noting that a the lack of data on medicines affordability and national pharmaceutical expenditures has hindered this process, according a recent article published in UK medical journal The Lancet. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 by David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> On World AIDS Day: Big Breakthroughs On HIV Self-Testing 30/11/2018 by Health Policy Watch A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading -> Index Finds Five Companies Develop Majority Of Medicines For Poor 20/11/2018 by David Branigan A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading -> Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Video: Stopping Malaria Relapse – New Approaches For An Old Disease 22/01/2019 by Editorial team Medicines for Malaria Venture (MMV) tells the story of the new single-dose tefanoquine treatment for relapsing malaria, caused by the Plasmodium vivax species of the parasite – the most widespread in the world. Continue reading -> Experts Call For Global Accountability Mechanism For Access To Essential Medicines 10/12/2018 by David Branigan Global health experts, including senior officials at the World Health Organization, are calling for a global accountability mechanism for access to essential medicines, noting that a the lack of data on medicines affordability and national pharmaceutical expenditures has hindered this process, according a recent article published in UK medical journal The Lancet. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 by David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> On World AIDS Day: Big Breakthroughs On HIV Self-Testing 30/11/2018 by Health Policy Watch A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading -> Index Finds Five Companies Develop Majority Of Medicines For Poor 20/11/2018 by David Branigan A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading -> Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Experts Call For Global Accountability Mechanism For Access To Essential Medicines 10/12/2018 by David Branigan Global health experts, including senior officials at the World Health Organization, are calling for a global accountability mechanism for access to essential medicines, noting that a the lack of data on medicines affordability and national pharmaceutical expenditures has hindered this process, according a recent article published in UK medical journal The Lancet. Continue reading -> New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 by David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> On World AIDS Day: Big Breakthroughs On HIV Self-Testing 30/11/2018 by Health Policy Watch A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading -> Index Finds Five Companies Develop Majority Of Medicines For Poor 20/11/2018 by David Branigan A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading -> Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Study Tracks Global Children’s Antibiotic Use, Finds Deviation From WHO Guidelines 07/12/2018 by David Branigan A new study has analysed antibiotic sales data from 70 middle-income and high-income countries, and found variation in the use of antibiotics to treat children, with some countries deviating from World Health Organization recommendations on antibiotic stewardship. Continue reading -> On World AIDS Day: Big Breakthroughs On HIV Self-Testing 30/11/2018 by Health Policy Watch A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading -> Index Finds Five Companies Develop Majority Of Medicines For Poor 20/11/2018 by David Branigan A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading -> Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
On World AIDS Day: Big Breakthroughs On HIV Self-Testing 30/11/2018 by Health Policy Watch A report launched jointly today by Population Services International (PSI), London School of Hygiene and Tropical Medicine and the World Health Organization shows that people’s knowledge of their HIV status in sub-Saharan African countries nearly doubled just four years after self-testing programmes were introduced. Separately, a group of French NGOs called on the French President to lead elimination of HIV/AIDS, tuberculosis and malaria by 2030. Continue reading -> Index Finds Five Companies Develop Majority Of Medicines For Poor 20/11/2018 by David Branigan A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading -> Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Index Finds Five Companies Develop Majority Of Medicines For Poor 20/11/2018 by David Branigan A global index on access to medicine has found that the majority of the medicines needed by the world’s poor are developed by only five companies, and that these medicines are focused primarily on just five diseases. The group behind the index calls on more pharmaceutical companies to join efforts for increased access and to expand the list of medicines, in order to build resilience in treating diseases that affect the poor. Continue reading -> Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Austria’s Director General For Health Clemens Auer Discusses Goals For EU, Drug Pricing 02/11/2018 by William New Clemens Martin Auer, director general of Austria’s Ministry of Health, could be said to take a pragmatic and original perspective when it comes to European and national policy. In an interview with Health Policy Watch during the recent European Health Forum in Bad Gastein, Austria, he discussed health priorities for the current Austrian presidency of the European Union and beyond. He also discussed ongoing efforts by a number of European countries to address high prices of medicines and public funding for R&D. This is the second of two parts. Continue reading -> Posts navigation Older posts